We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+14.33%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$6.91B
AUM Growth
+$82.5M
Cap. Flow
-$567M
Cap. Flow %
-8.2%
Top 10 Hldgs %
24.12%
Holding
865
New
42
Increased
270
Reduced
470
Closed
20

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$34.6M
2
WMT icon
Walmart Inc
WMT
+$12.2M
3
NVDA icon
NVIDIA
NVDA
+$8.11M
4
EOLS icon
Evolus
EOLS
+$7.02M
5
ABBV icon
AbbVie
ABBV
+$6.93M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$335M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$17.9M
3
RCL icon
Royal Caribbean
RCL
+$12.1M
4
GLNG icon
Golar LNG
GLNG
+$12M
5
AAPL icon
Apple
AAPL
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 23.46%
2 Financials 11.35%
3 Healthcare 9.92%
4 Industrials 8.66%
5 Communication Services 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NU icon
826
Nu Holdings
NU
$70.9B
$153K ﹤0.01%
11,145
-6,962
-38% -$83.4K
SIFY
827
Sify Technologies
SIFY
$1.03B
$153K ﹤0.01%
33,236
-796
-2% -$3.59K
ARCO icon
828
Arcos Dorados Holdings
ARCO
$1.77B
$131K ﹤0.01%
16,600
+5,500
+50% +$41.6K
SPFF icon
829
Global X SuperIncome Preferred ETF
SPFF
$140M
$125K ﹤0.01%
13,928
– –
WEN icon
830
Wendy's
WEN
$1.46B
$115K ﹤0.01%
10,040
– –
RWT
831
Redwood Trust
RWT
$587M
$114K ﹤0.01%
19,250
+8,118
+73% +$46.1K
VTRS icon
832
Viatris
VTRS
$20.8B
$111K ﹤0.01%
+12,383
New +$105K
NUV icon
833
Nuveen Municipal Value Fund
NUV
$1.91B
$110K ﹤0.01%
12,639
– –
VOD icon
834
Vodafone
VOD
$37.7B
$107K ﹤0.01%
10,067
-163
-2% -$1.58K
BHK icon
835
BlackRock Core Bond Trust
BHK
$646M
$102K ﹤0.01%
10,481
-624
-6% -$6.31K
WWR icon
836
Westwater Resources
WWR
$51.6M
$82.7K ﹤0.01%
137,500
+3,600
+3% +$1.89K
LOCL icon
837
Local Bounti
LOCL
$23.3M
$72.2K ﹤0.01%
30,845
– –
GERN icon
838
Geron
GERN
$930M
$71.2K ﹤0.01%
50,505
-2,000
-4% -$2.83K
DWSN icon
839
Dawson Geophysical
DWSN
$137M
$64.2K ﹤0.01%
44,000
-6,422
-13% -$8.74K
ESPR
840
DELISTED
Esperion Therapeutics
ESPR
$60.2K ﹤0.01%
61,105
-320
-0.5% -$320
CIK
841
Credit Suisse Asset Management Income Fund
CIK
$134M
$51.6K ﹤0.01%
17,440
– –
LXRX icon
842
Lexicon Pharmaceuticals
LXRX
$1.04B
$48.1K ﹤0.01%
50,815
-3,365
-6% -$2.18K
ABOS icon
843
Acumen Pharmaceuticals
ABOS
$165M
$20.9K ﹤0.01%
18,020
– –
CCO icon
844
Clear Channel Outdoor Holdings
CCO
$1.23B
$17.6K ﹤0.01%
15,000
– –
CRBU icon
845
Caribou Biosciences
CRBU
$148M
$16.3K ﹤0.01%
12,903
– –
ATAT icon
846
Atour Lifestyle Holdings
ATAT
$4.77B
– –
-7,500
Closed -$213K
BATL icon
847
Battalion Oil
BATL
$28.2M
– –
-10,000
Closed -$13K
CNC icon
848
Centene
CNC
$31.6B
– –
-4,258
Closed -$259K
DFS
849
DELISTED
Discover Financial Services
DFS
– –
-29,898
Closed -$5.1M
EEM icon
850
iShares MSCI Emerging Markets ETF
EEM
$28B
– –
-4,825
Closed -$211K
31 32 33
34
35

Similar funds

EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Pinnacle Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Pinnacle Associates held 865 positions worth $6.91B, up 1.2% from $6.82B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Pinnacle Associates withdrew a net $567M in Q2 2025, closing 20 positions and reducing 470 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Pinnacle Associates opened a new position in Evolus worth $6.32M.

  • Pinnacle Associates's largest Q2 2025 buy was Evolus: 685,960 shares worth $6.32M.
  • Pinnacle Associates added most to Vanguard Total Stock Market ETF in Q2 2025, an estimated $34.6M increase.
  • Pinnacle Associates's biggest Q2 2025 reduction was Johnson & Johnson, cutting an estimated $335M.
  • Pinnacle Associates fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $17.9M.
  • Pinnacle Associates's ten largest holdings make up 24% of its $6.91B portfolio in Q2 2025.
  • Pinnacle Associates opened 42 new positions and closed 20 in Q2 2025.
  • Pinnacle Associates's portfolio value rose 1.2% quarter-over-quarter to $6.91B.

Based on Pinnacle Associates's 13F filing for Q2 2025, filed 4 Aug 2025.